Assessment and Classification of Disease Prognosis
INACTIVE REVIEW: This measure review is older than five years.
Percentage of patients 18 years and older with a diagnosis of rheumatoid arthritis (RA) who have an assessment and classification of disease prognosis at least once within 12 months.
ACP does not support PQRS 179: “Assessment and Classification of Disease Prognosis.” ACP does not support this measure because there is no evidence supporting annual frequency or describing appropriate frequency for assessment or classification of disease prognosis. Additionally, it seems unnecessary to reassess prognosis annually if a poor prognosis has been established based on factors that will not change such as high titer anti-citric citrullinated peptide (anti-CCP) antibodies, rheumatoid factor (RF) or radiographic erosions.